Navigation Links
Cabinet Clears Purchase Preference Policy for Pharma PSUs

The Government today said the central departments, public sector undertakings and autonomous bodies will give first preference to central pharma PSUs like IDPL// and their subsidiaries for purchasing 102 medicines for a period of five years.

As per a decision of the Cabinet, which met here today, the first preference will also be given to these pharma PSUs and their subsidiaries by state governments in their purchases which are funded by the Centre.

The purchasing departments may invite limited tenders from pharma PSUs and their subsidiaries or purchase directly from them at notified price with a discount up to 35 per cent, Information and Broadcasting Minister P R Dasmunsi told reporters after the Cabinet meeting.

If no pharma CPSE is forthcoming to supply these medicines, the purchasing departments would be at liberty to buy from other manufacturers, I& B Minister P R Dasmunsi said.

The purchasing departmens would purchase from these PSUs, and their subsidiaries, subject to their meeting Good Manufacturing Practices norms.

The purpose of the Purchase Preference Policy is to make available quality drugs under various health schemes and help in optimum utilisation of assets of these public sector units, Dasmunsi said.

The size of pharma market in the country stands at Rs 50,000 crore, including exports of around Rs 17,000 crore. Of this, central departments purchase around Rs 2,000 crore of medicines and state governments account for another Rs 1,500-2,000 crore per annum for their health programmes.

Source:PTI News
'"/>




Page: 1

Related medicine news :

1. Business model for Liver Institute cleared by Delhi Cabinet
2. Baby Acne Clears Up On Its Own
3. SC Clears Deck For Implementation Of Nutrition Scheme
4. Bangkoks Public Health Ministry Clears The Northern Province Of Bird Flu Epidemic
5. European Commission Clears Diabetic Insulin for Pregnant Women
6. Delhi Government Clears Healthcare Projects Worth Rs.1.13 bn
7. FDA Clears Breast Cancer Specific Molecular Prognostic Test
8. FDA Clears Critical Limb-Saving Vascular Device
9. The Risks Involved In Purchase Of Over The Counter Medications
10. Online Auction Results In Purchase of Chemicals
11. Aurobindo Pharma Purchases US Manufacturing Facility
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/26/2017)... Washington, DC (PRWEB) , ... July 26, 2017 ... ... Arise Infusion is pleased to now offer a major advancement in drug therapy ... their lives. Ocrevus (pronounced Ah-creh-vus) is a novel B cell targeted therapy ...
(Date:7/26/2017)... Yorba Linda, Ca (PRWEB) , ... July 26, 2017 , ... ... of optimize lyophilization processes. Inconsistent results freeze drying samples and a lengthy freeze dry ... , This webinar will discuss freeze drying techniques, as well as new accessories and ...
(Date:7/26/2017)... ... July 26, 2017 , ... ... host its 2017 Process Validation and Process Validation Statistics Conferences in Bethesda, ... process validation lifecycle challenges faced by process validation professionals and statisticians today. ...
(Date:7/26/2017)... ... ... Team Type 1 Foundation, a nonprofit organization pursuing a global mission of education, ... announce the 106 college athletes with type 1 diabetes who will receive scholarships as ... 1 Foundation has bestowed a total of 271 college scholarships to athletes with type ...
(Date:7/26/2017)... ... July 26, 2017 , ... IDC-Eating Disorder Care ... the treatment program located in Royal Oak, Michigan. IDC, formerly known as ... focused on providing the highest standards in the field of eating disorder treatment in ...
Breaking Medicine News(10 mins):
(Date:7/14/2017)... , July 13, 2017 It should come ... States is in the midst of a crippling ... , since 1999, the number of overdose deaths from opiate-based ... in over half a million dead from 2001 to 2015". ... oxycodone, and hydrocodone has similarly quadrupled, drawing a compelling link ...
(Date:7/12/2017)... , July 12, 2017  Eli Lilly and Company (NYSE: ... with generic companies to resolve pending patent litigation in the ... Virginia regarding the Cialis ® (tadalafil) unit ... April 26, 2020. As part of the agreement, Cialis exclusivity ... 27, 2018. "The unit dose patent for Cialis ...
(Date:7/11/2017)... SARASOTA, Fla. , July 11, 2017  Dr. Echenberg, founder of ... Dilator therapy program to patients who suffer from painful intercourse and other ... vaginismus and vaginal atrophy due to menopause. ... VuVatech LLC ... Dilators , created by Sarasota, Florida -based start-up company, ...
Breaking Medicine Technology: